Education
About Us
Working with TipRanks
Follow Us
Canton Strategic Holdings (CNTN)
NASDAQ:CNTN
CNTN Stock Chart & Stats
$4.05
-$0.07(-3.02%)
At close: 4:00 PM EST
$4.05
-$0.07(-3.02%)
Day’s Range― - ―
52-Week Range$0.95 - $9.08
Previous CloseN/A
VolumeN/A
Average Volume (3M)636.65K
Market Cap
$203.50M
Enterprise Value$148.53M
Total Cash (Recent Filing)$7.61M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.62
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-9.68
Shares Outstanding51,518,536
10 Day Avg. Volume300,267
30 Day Avg. Volume636,647
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)2.01
Price to Sales (P/S)0.00
P/FCF Ratio-0.24
Enterprise Value/Market Cap0.73
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-14.43
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering0
EPS Forecast (FY)-0.75
Revenue Forecast (FY)N/A
Canton Strategic Holdings News
CNTN FAQ
What was Canton Strategic Holdings’s price range in the past 12 months?
Canton Strategic Holdings lowest stock price was $0.95 and its highest was $9.08 in the past 12 months.
What is Canton Strategic Holdings’s market cap?
Canton Strategic Holdings’s market cap is $203.50M.
When is Canton Strategic Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Canton Strategic Holdings’s earnings last quarter?
Currently, no data Available
Is Canton Strategic Holdings overvalued?
According to Wall Street analysts Canton Strategic Holdings’s price is currently Overvalued.
Does Canton Strategic Holdings pay dividends?
Canton Strategic Holdings does not currently pay dividends.
What is Canton Strategic Holdings’s EPS estimate?
Canton Strategic Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Canton Strategic Holdings have?
Canton Strategic Holdings has 51,518,536 shares outstanding.
What happened to Canton Strategic Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Canton Strategic Holdings?
Currently, no hedge funds are holding shares in CNTN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Canton Strategic Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
― (―)
― (―)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.8%
Last 30 Days ▼ 9.0%
Last 30 Days ▼ 9.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
22.12%
12-Months-Change
Fundamentals
Return on Equity
-340.26%
Trailing 12-Months
Asset Growth
-69.36%
Trailing 12-Months
Company Description
Canton Strategic Holdings
Canton Strategic Holdings, Inc. focuses on leveraging Canton Coin and supporting the Canton network to advance institutional blockchain adoption and the digitization of financial markets. The company also involved in research and development of GV104, a buccal film technology, which has completed Phase 1 trial for respiratory and/or nervous system depression in military personnel and chemical incident responders; and GV023, an oral formulation of infliximab, addresses a critical limitation of the IV gold standard by eliminating the treatment burden of repeated intravenous infusions. The company was formerly known as Tharimmune, Inc. and changed its name to Canton Strategic Holdings, Inc. in February 2026. Canton Strategic Holdings, Inc. was founded in 2017 and is based in Red Bank, New Jersey.
Technical Analysis
CervoMed
―
―
Champions Oncology
―
Pelthos Therapeutics
―
Artiva Biotherapeutics, Inc.
―
Ownership Overview
1.56% Insiders
0.82% Mutual Funds
10.82% Other Institutional Investors
85.25% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---